Ranibizumab for Choroidal Neovascularization Secondary to Causes Other Than Age-Related Macular Degeneration: A Phase I Clinical Trial

201049 citationsJournal Article

Authors

Good health and well-being

Published in: Ophthalmology

Volume 118, Issue 1, pp. 111-118

Field-Weighted Citation Impact: 4.56